Prohost Biotech - Exclusive Biotech Research - A Comprehensive Resource for Biotech News

The Time Has Come for Agenus to Excel. See Also: Why Evoke Pharma Traded UP Today

June 22, 2020 0

Agenus Has Two Separate Press Releases In the First Press Release from Agenus: Agenus (AGEN) announced …

Good News for Four Companies: Jazz, Celldex, Inventiva & Illumina

June 17, 2020 0

Good News for Jazz, Celldex, Inventiva & Illumina Jazz Pharmaceuticals Good News Jazz Pharmaceuticals (JAZZ) announced along with …

Illumina’s COVIDSeq Test Granted Emergency Use Authorization. See Also: CRISPR Therapeutics and Vertex Encouraging News

June 15, 2020 0

Illumina Diagnostic Test COVIDSeq to Detect SARS-CoV-2 Illumina (ILMN) was issued an Emergency Use Authorization (EUA) …

Celldex Therapeutics: The Beginning of the Firm’s Resurrection

June 12, 2020 0

Celldex Therapeutics A few years ago Celldex Therapeutics (CLDX) was known for its superior pipeline products. …

Reata Pharmaceuticals Stock Soared

June 11, 2020 0

Reata Pharmaceuticals Stock is Flying High Here is another example of why analysts can no longer …

Moderna Speeding Towards Delivering the Awaited Novel Coronavirus Prophylactic Vaccine

June 11, 2020 0

Moderna mRNA-1273 Vaccine for COVID-19 The market is expected to open DOWN today. Moderna’s (MRNA) stock …

Has the Time Come for Curis Inc to Flex Its Muscles?

June 10, 2020 0

Curis Inc IND Application Cleared by the US FDA Curis Inc (CRIS) announced that the U.S. …

A Potential Merger Between AstraZeneca Plc and Gilead Sciences?

June 8, 2020 0

AstraZeneca Plc and Gilead Sciences Potential Merger News spread through the media announcing that AstraZeneca Plc …

Myovant Sciences Recent News is Good for Prostate Cancer Patients

June 3, 2020 0

Myovant Sciences Good News A lot of positive news is emanating from clinical trials conducted by …

Compugen: Predictive Computational Discovery Technology

June 1, 2020 0

Compugen IND Application for Triple Combination Study Cleared by the US FDA The U.S. Food and …

Why Sonoma Pharmaceuticals and Adaptimmune Stock Prices Skyrocketed

May 29, 2020 0

Sonoma Pharmaceuticals and MicroSafe Group, Dubai Sonoma Pharmaceuticals (SNOA) develops stabilized hypochlorous acid (HOCl) products for …

Questions & Answers

May 27, 2020 0

The Week in Review #51 Questions & Answers About CytomX Q: Is there any reason for …

Encouraging Results From Nektar’s Product BEMPEG: NKTR-214 In Combination with the Checkpoint Inhibitor Nivolumab

May 22, 2020 0

Nektar Therapeutics Nektar Therapeutics (NKTR) announced the publication of Phase 1 clinical data for its immuno-oncology candidate, …

Navidea Biopharmaceuticals: Why This Small Firm’s Stock Skyrocketed

May 22, 2020 0

Navidea Biopharmaceuticals Stock Soared Navidea Biopharmaceuticals (NAVB) stock price jumped from $1.27 to $3.04 this morning. …

Gilead Sciences and Galapagos NV: Good News from Filgotinib in Ulcerative Colitis

May 21, 2020 0

Gilead Sciences and Galapagos NV Announce Good News from Filgotinib Trial Gilead Sciences (GILD) and Galapagos …

Inovio: INO-4800 DNA Vaccine Against the Novel Coronavirus Has Promising News. Moderna Still Has the Front-Runner

May 20, 2020 0

Inovio DNA Vaccine Candidate INO-4800 for SARS-CoV-2 Inovio (INO) announced the publication of the preclinical study …

Moderna: Pricing of a Public Offering of 17,600,000 Shares at $76.00 Per Share

May 19, 2020 0

Moderna Inc: A Public Offering Moderna (MRNA) announced the pricing of an underwritten public offering of …

Moderna: Positive Interim Phase 1 Data for its mRNA-1273 Vaccine Against Novel Coronavirus

May 18, 2020 0

Moderna Postive News for mRNA-1273 Vaccine Against Novel Coronavirus (COVID-19) Moderna (MRNA) announced positive interim clinical …

Sorrento Therapeutics: STI-1499 ~ An Encouraging Anti-SARS-CoV-2 Antibody

May 16, 2020 0

Sorrento Therapeutics Anti-SARS-CoV-2 Antibody STI-1499 Sorrento Therapeutics (SRNE) announced that its anti-SARS-CoV-2 antibody, STI-1499, demonstrated 100% …

Bristol-Myers Squibb and bluebird bio Product Ide-Cel, Bb2121 and the FDA Refusal Letter. What Do We Expect?

May 13, 2020 0

Bristol-Myers Squibb and bluebird bio Bristol-Myers Squibb (BMY) and bluebird bio (

Exclusive Market Insight

& Scientific analysis

Latest Articlesddd

The Time Has Come for Agenus to Excel. See Also: Why Evoke Pharma Traded UP Today

Good News for Four Companies: Jazz, Celldex, Inventiva & Illumina

Illumina’s COVIDSeq Test Granted Emergency Use Authorization. See Also: CRISPR Therapeutics and Vertex Encouraging News

Celldex Therapeutics: The Beginning of the Firm’s Resurrection

Reata Pharmaceuticals Stock Soared

Moderna Speeding Towards Delivering the Awaited Novel Coronavirus Prophylactic Vaccine

Has the Time Come for Curis Inc to Flex Its Muscles?

A Potential Merger Between AstraZeneca Plc and Gilead Sciences?

Myovant Sciences Recent News is Good for Prostate Cancer Patients

Compugen: Predictive Computational Discovery Technology

Why Sonoma Pharmaceuticals and Adaptimmune Stock Prices Skyrocketed

Questions & Answers

Encouraging Results From Nektar’s Product BEMPEG: NKTR-214 In Combination with the Checkpoint Inhibitor Nivolumab

Navidea Biopharmaceuticals: Why This Small Firm’s Stock Skyrocketed

Gilead Sciences and Galapagos NV: Good News from Filgotinib in Ulcerative Colitis

Inovio: INO-4800 DNA Vaccine Against the Novel Coronavirus Has Promising News. Moderna Still Has the Front-Runner

Moderna: Pricing of a Public Offering of 17,600,000 Shares at $76.00 Per Share

Moderna: Positive Interim Phase 1 Data for its mRNA-1273 Vaccine Against Novel Coronavirus

Sorrento Therapeutics: STI-1499 ~ An Encouraging Anti-SARS-CoV-2 Antibody

Bristol-Myers Squibb and bluebird bio Product Ide-Cel, Bb2121 and the FDA Refusal Letter. What Do We Expect?